Variant report

Variant	rs8101992
Chromosome Location	chr19:18614423-18614424
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr19:18611870..18615199-chr19:18629842..18634728,4	MCF-7	breast:
2	chr19:18599219..18600750-chr19:18614089..18616331,2	MCF-7	breast:
3	chr19:18611969..18615434-chr19:18616627..18618561,3	K562	blood:
4	chr19:18612893..18615470-chr19:18630495..18632321,2	MCF-7	breast:
5	chr19:18612681..18614688-chr19:18619411..18621662,2	K562	blood:
6	chr19:18611587..18620542-chr19:18622883..18629236,13	MCF-7	breast:
7	chr19:18606523..18611350-chr19:18611496..18616522,8	K562	blood:

Variant related genes	Relation type
ENSG00000105656	Chromatin interaction

Extended variants
information (count: 20 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:10)

rs_ID	r²[population]
rs187957	0.84[AFR][1000 genomes];0.95[AMR][1000 genomes];0.99[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs2303693	1.00[CHB][hapmap];1.00[JPT][hapmap];0.87[YRI][hapmap];0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs2303694	0.81[AFR][1000 genomes];0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs2314670	0.86[AFR][1000 genomes];0.84[ASN][1000 genomes]
rs3746176	1.00[CHB][hapmap];1.00[JPT][hapmap];0.94[YRI][hapmap];0.84[AFR][1000 genomes];0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs7246328	0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs7251067	1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs8102195	0.84[ASN][1000 genomes]
rs8103520	0.81[AFR][1000 genomes];0.88[AMR][1000 genomes];0.94[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs8107222	0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:10 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	esv3323899	chr19:18343484-18620429	Enhancers Weak transcription Strong transcription Active TSS ZNF genes & repeats Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA	162 gene(s)	inside rSNPs	diseases
2	nsv911274	chr19:18440942-18691942	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	83 gene(s)	inside rSNPs	diseases
3	nsv1057795	chr19:18453362-18883844	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	92 gene(s)	inside rSNPs	diseases
4	nsv543925	chr19:18453362-18883844	Weak transcription Genic enhancers Strong transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	92 gene(s)	inside rSNPs	diseases
5	nsv428018	chr19:18454891-18663981	Enhancers Genic enhancers Weak transcription Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA	61 gene(s)	inside rSNPs	diseases
6	nsv1060687	chr19:18522527-18643218	Genic enhancers Strong transcription Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	54 gene(s)	inside rSNPs	diseases
7	nsv532615	chr19:18534867-18796031	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	71 gene(s)	inside rSNPs	diseases
8	nsv1061733	chr19:18574940-18679155	Weak transcription Genic enhancers Enhancers Flanking Active TSS Strong transcription ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	32 gene(s)	inside rSNPs	diseases
9	nsv1055794	chr19:18611545-18676933	Weak transcription Active TSS Enhancers Flanking Active TSS Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	30 gene(s)	inside rSNPs	diseases
10	nsv911281	chr19:18613917-18758255	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	51 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:108 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:18594000-18621800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
2	chr19:18600400-18630600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
3	chr19:18600600-18619800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
4	chr19:18602200-18621400	Enhancers	Right Ventricle	heart
5	chr19:18602600-18621400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
6	chr19:18603600-18622600	Enhancers	Psoas Muscle	Psoas
7	chr19:18604200-18619000	Enhancers	Fetal Thymus	thymus
8	chr19:18604800-18618400	Enhancers	Primary monocytes fromperipheralblood	blood
9	chr19:18605400-18621800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
10	chr19:18606800-18614600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
11	chr19:18606800-18625800	Weak transcription	H1 Cell Line	embryonic stem cell
12	chr19:18607000-18615000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
13	chr19:18607200-18617800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
14	chr19:18607600-18617600	Enhancers	Primary T cells fromperipheralblood	blood
15	chr19:18607600-18618000	Enhancers	Primary T helper cells PMA-I stimulated	--
16	chr19:18607600-18621600	Enhancers	Primary T killer memory cells from peripheral blood	blood
17	chr19:18607600-18622400	Enhancers	Primary T helper cells fromperipheralblood	blood
18	chr19:18608000-18614800	Weak transcription	Fetal Kidney	kidney
19	chr19:18608000-18615800	Weak transcription	Pancreatic Islets	Pancreatic Islet
20	chr19:18608400-18617200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
21	chr19:18608400-18617200	Weak transcription	K562	blood
22	chr19:18609000-18615600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
23	chr19:18609200-18617800	Enhancers	Adipose Nuclei	Adipose
24	chr19:18609200-18619600	Enhancers	Duodenum Smooth Muscle	Duodenum
25	chr19:18609200-18620800	Enhancers	Brain Hippocampus Middle	brain
26	chr19:18609200-18621400	Enhancers	Fetal Muscle Trunk	muscle
27	chr19:18609200-18621400	Enhancers	Rectal Mucosa Donor 31	rectum
28	chr19:18609200-18621400	Enhancers	Sigmoid Colon	Sigmoid Colon
29	chr19:18609200-18621600	Enhancers	Liver	Liver
30	chr19:18609200-18621600	Enhancers	Left Ventricle	heart
31	chr19:18609400-18618400	Weak transcription	Thymus	Thymus
32	chr19:18609400-18621400	Enhancers	Lung	lung
33	chr19:18609400-18621600	Enhancers	Pancreas	Pancrea
34	chr19:18609800-18620200	Enhancers	Gastric	stomach
35	chr19:18609800-18621000	Enhancers	Fetal Muscle Leg	muscle
36	chr19:18609800-18621400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
37	chr19:18609800-18621800	Enhancers	Right Atrium	heart
38	chr19:18610200-18620800	Enhancers	Fetal Heart	heart
39	chr19:18610400-18616800	Enhancers	GM12878-XiMat	blood
40	chr19:18610800-18616400	Weak transcription	Primary T cells from cord blood	blood
41	chr19:18611000-18615200	Enhancers	Brain Substantia Nigra	brain
42	chr19:18611000-18620200	Enhancers	Brain Cingulate Gyrus	brain
43	chr19:18611000-18621400	Enhancers	Small Intestine	intestine
44	chr19:18611200-18618200	Enhancers	Brain Anterior Caudate	brain
45	chr19:18611200-18619400	Enhancers	Esophagus	oesophagus
46	chr19:18611200-18621600	Enhancers	Brain Inferior Temporal Lobe	brain
47	chr19:18611400-18615200	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
48	chr19:18611400-18615400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
49	chr19:18611400-18618400	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
50	chr19:18611400-18621600	Enhancers	Breast Myoepithelial Primary Cells	Breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links